TERT/TERC (Telomerase Reverse Transcriptase/RNA Component): Telomerase activation in NSCLC arises via promoter mutations and/or amplification, with liquid-biopsy TERT showing diagnostic/prognostic value. The gene discussed is TERT; the disease is non-small cell lung carcinoma.